Direct-Acting Oral Anticoagulants (DOAC) Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
doac score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low0–3
  • Low4–5
  • Moderate6–7
  • High8–9
Direct Clinical Answer

The Direct-Acting Oral Anticoagulants (DOAC) Score calculates predicting bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants. Key inputs include age category. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants

Clinical Indication

The Direct-Acting Oral Anticoagulants (DOAC) Score is indicated for bedside clinical practice to support Predicts bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

DOAC Score = Age points + Creatinine clearance points + Sum of risk factors (underweight, stroke/TIA/embolism history, diabetes, hypertension, antiplatelet use, NSAID use, bleeding history, liver disease). Maximum score is capped at 10 points.

Input Parameters

NameTypeRequiredDescription
age_categorystringYesPatient age category for bleeding risk assessment
creatinine_clearance_categorystringYesCreatinine clearance category
underweightstringYesBMI <18.5 kg/m²
stroke_tia_embolism_historystringYesHistory of stroke, TIA, or systemic embolism
diabetesstringYesDiabetes mellitus
hypertensionstringYesHypertension
antiplatelet_usestringYesCurrent antiplatelet agent use (aspirin, clopidogrel, etc.)
nsaid_usestringYesCurrent NSAID use
bleeding_historystringYesHistory of major bleeding
liver_diseasestringYesLiver disease

Score Interpretation & Guidance

RangeStageDescription
0–3Very LowVery low bleeding risk
4–5LowLow bleeding risk
6–7ModerateModerate bleeding risk
8–9HighHigh bleeding risk
10–10Very HighVery high bleeding risk

Evidence-Based References (EBM)

  • Aggarwal A, Wang TY, Rumsfeld JS, et al. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants. Circulation. 2023 Nov 7;148(19):1482-1492. doi: 10.1161/CIRCULATIONAHA.123.064556.DOI: 10.1161/CIRCULATIONAHA.123.064556
  • Costa OS, Beyer-Westendorf J, Ashton V, et al. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry. Thromb Res. 2024 Aug;240:109063. doi: 10.1016/j.thromres.2024.109063.DOI: 10.1016/j.thromres.2024.109063

Related calculators